2026 Life Sciences Industry Outlook Report

This report provides an outlook on the life sciences industry for 2026, detailing key trends and developments from 2025 that influence the upcoming year. It outlines the significant acceleration in mergers and acquisitions (M&A) activity, noting that 2025 marked one of the busiest years on record due to improved financing conditions and regulatory clarity. The report highlights the return of large transactions and the ongoing trend of smaller bolt-on acquisitions. It also discusses the evolving regulatory environment, which is expected to impact M&A dynamics in 2026. Additionally, the report addresses the capital markets, noting a stark contrast between the first and second halves of 2025, with a significant rebound in equity offerings and IPOs. Royalty finance is identified as a growing area, with transaction values reaching record levels. Overall, the report presents a cautiously optimistic view of the life sciences sector, emphasizing the interplay of market conditions and regulatory factors that will shape the industry in 2026.